E-LIB Suche - Ergebnisse für: Oberoi, Rajneet K.

1

Efficacy and safety of apremilast in pediatric patients wit..:

Fiorillo, Loretta ; Becker, Emily ; de Lucas, Raul...
Journal of the American Academy of Dermatology. 90 (2024) 6 - p. 1232-1239 , 2024

Link: https://doi.org/10.1016/..

2

A GIPR antagonist conjugated to GLP-1 analogues promotes we..:

Véniant, Murielle M. ; Lu, Shu-Chen ; Atangan, Larissa...
Nature Metabolism. 6 (2024) 2 - p. 290-303 , 2024

Link: https://doi.org/10.1038/..

3

Pharmacokinetics, Tolerability, and Safety of Glecaprevir/P..:

Kalluri, Hari V. ; Oberoi, Rajneet K. ; Chen, Qian...
Clinical Pharmacology in Drug Development. 12 (2023) 10 - p. 945-955 , 2023

Link: https://doi.org/10.1002/..

4

42163 Apremilast in Pediatric Patients With Moderate to Sev..:

Fiorillo, Loretta ; Becker, Emily ; de Lucas, Raul...
Journal of the American Academy of Dermatology. 89 (2023) 3 - p. AB122 , 2023

Link: https://doi.org/10.1016/..

5

Apremilast in Pediatric Patients With Moderate to Severe Pl..:

Fiorillo, Loretta ; Becker, Emily ; Lucas, Raul de...
SKIN The Journal of Cutaneous Medicine. 7 (2023) 6 - p. s254 , 2023

Link: https://doi.org/10.25251..

6

Effect of Varying Degrees of Hepatic Impairment on the Phar..:

Trivedi, Ashit ; Oberoi, Rajneet K. ; Mackowski, Mia...
Clinical Pharmacology in Drug Development. 10 (2021) 12 - p. 1442-1451 , 2021

Link: https://doi.org/10.1002/..

7

Effect of Omecamtiv Mecarbil on the Pharmacokinetics of Met..:

Trivedi, Ashit ; Oberoi, Rajneet K. ; Jafarinasabian, Pegah...
Clinical Drug Investigation. 41 (2021) 7 - p. 647-652 , 2021

Link: https://doi.org/10.1007/..

8

Effect of Varying Degrees of Renal Impairment on the Pharma..:

Trivedi, Ashit ; Oberoi, Rajneet K. ; Jafarinasabian, Pegah...
Clinical Pharmacokinetics. 60 (2021) 8 - p. 1041-1048 , 2021

Link: https://doi.org/10.1007/..

9

Switchability and minimal effect of food on pharmacokinetic..:

Trivedi, Ashit ; Oberoi, Rajneet K. ; Mackowski, Mia...
Biopharmaceutics & Drug Disposition. 42 (2021) 7 - p. 319-328 , 2021

Link: https://doi.org/10.1002/..

10

A Thorough QT Study of the Combination Glecaprevir + Pibren..:

Oberoi, Rajneet K. ; Zhao, Weihan ; Rosebraugh, Matthew...
Clinical Therapeutics. 42 (2020) 7 - p. 1317-1329 , 2020

Link: https://doi.org/10.1016/..

11

Exposure–Response Relationships for the Efficacy and Safety..:

Suleiman, Ahmed A. ; Khatri, Amit ; Oberoi, Rajneet K..
Clinical Pharmacokinetics. 59 (2019) 5 - p. 575-589 , 2019

Link: https://doi.org/10.1007/..

12

Population Pharmacokinetics of Glecaprevir/Pibrentasvir in ..:

Suleiman, Ahmed Abbas ; Lin, Chih‐Wei ; Liu, Wei...
The Journal of Clinical Pharmacology. 60 (2019) 3 - p. 331-339 , 2019

Link: https://doi.org/10.1002/..

13

Efficacy and Pharmacokinetics of Glecaprevir and Pibrentasv..:

Flamm, Steven ; Reddy, K. Rajender ; Zadeikis, Neddie...
Clinical Gastroenterology and Hepatology. 17 (2019) 3 - p. 527-535.e6 , 2019

Link: https://doi.org/10.1016/..

14

A Phase 1 Study to Evaluate the Effect of Crushing, Cutting..:

Oberoi, Rajneet K. ; Zhao, Weihan ; Sidhu, Dilraj S....
Journal of Pharmaceutical Sciences. 107 (2018) 6 - p. 1724-1730 , 2018

Link: https://doi.org/10.1016/..

15

Efficacy and safety of glecaprevir/pibrentasvir in HCV-infe..:

Kumada, Hiromitsu ; Watanabe, Tsunamasa ; Suzuki, Fumitaka...
Journal of Gastroenterology. 53 (2017) 4 - p. 566-575 , 2017

Link: https://doi.org/10.1007/..